title: Is clinical tolerance possible after allergen immunotherapy?
abstract: There is a growing evidence that allergen immunotherapy (AIT) can provide significant and long-lasting clinical benefit for a number of allergic individuals. However, it is less clear if AIT results in clinical tolerance, which is characterized by a persistent state of clinical non-reactivity to allergens after therapy is finished. Addressing this knowledge gap is particularly relevant for patients undergoing AIT for food allergies, as anything less than complete tolerance could have potentially devastating consequences. An increasing number of studies, in particular those involving oral immunotherapy, are attempting to assess tolerance induction following AIT. Clinical tolerance does appear to be achievable in a subset of patients undergoing AIT, but whether this is equivalent to the type of tolerance observed in nonallergic individuals remains unknown. Developing established criteria for assessing tolerance induction, as well as the use of consistent terminology when describing clinical tolerance, will be important for determining the disease-modifying potential of AIT.
authors.affiliation: Department of Pediatrics, The University of North Carolina School of Medicine, 104 Mason Farm Road Campus, Box 7310, Chapel Hill, NC, 27599-7310, USA, tmoran@email.unc.edu.
authors.forename: Timothy P
authors.initials: TP
authors.lastname: Moran
authors.forename: A Wesley
authors.initials: AW
authors.lastname: Burks
mesh_terms: D000485:Allergens / Q000276:immunology; D003888:Desensitization, Immunologic / Q000379:methods; D005512:Food Hypersensitivity / Q000628:therapy; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D012120:Respiration Disorders / Q000628:therapy
chemical_list: D000485:Allergens